Cupid Limited
Our verdict
Financial trend (100/100) does the heavy lifting; valuation (0/100) is the drag.
Our fair value
Overvalued by 50%Buy-below (20% margin of safety): ₹146.38
TickerMagic rates Cupid Limited a Hold, scoring 45/100 on our blended model. At ₹365.95 it trades above our blended DCF and relative-multiples fair value of ₹182.98, about 50% downside to that estimate — we read it as overvalued by 50%. The price is about 5% below its 52-week high of ₹384.8 and 472% above the low of ₹63.99. Financial health scores 100/100, in the safe band on the Altman Z-score, with a Piotroski F-score of 4/9. It clears 10 of 13 investability checks, with durability 98, valuation 0 and momentum 93 on our 0–100 scales.
Analysis by Ankit Sharma · TickerMagic's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹146.38. Low-confidence estimate — limited data.
1-year price
EOD · 2026-11-2052-week range
-4.90% from the 52-week high.
Price above both moving averages reads as an intact uptrend; below both, the trend is against you.
Verdict pillars
Hold45Piotroski F-score 4/9 — quality of earnings & balance sheet.
Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Investability checklist
- Pass: ROE above 15%: 27.3%
- Pass: Low debt (D/E < 0.5): 0.13x
- Pass: Positive free cash flow
- Pass: Revenue growth > 10%: 112%
- Pass: Earnings growing: 214%
- Pass: Net margin ≥ 10%: 28.9%
- Pass: Current ratio > 1.5: 4.67
- Fail: Below our fair value
- Fail: Margin of safety ≥ 20%
- Pass: Above 200-day average
- Pass: Above 50-day average
- No data: Positive 1-year return
- Pass: Altman Z in safe zone: Z 169.34
- Fail: Piotroski ≥ 7: 4/9
Shareholding
- Promoter65.5%
- Institutions0.5%
- Public & other33.9%
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
Bull case vs bear case
Bull case
Strengths
- Strong return on equity (27.3%).
- Lightly leveraged balance sheet.
- Healthy profit margin (28.9%).
- Financially solid — Altman Z 169.34.
Opportunities
- Earnings growing (214% YoY).
- Revenue growing (112% YoY).
Bear case
Threats
- Rich valuation versus sector peers.
- Trades ~50% above our estimated fair value.
About Cupid Limited
Cupid Limited designs, manufactures, markets, and exports condoms and water-based lubricant jellies in India. The company produces in vitro diagnostic kits for infectious diseases, including HIV, hepatitis B and C, dengue, malaria, syphilis, and typhoid, as well as reproductive health tests for pregnancy and ovulation detection.
Cupid Limited — frequently asked questions
Is Cupid Limited a buy, hold or sell?
TickerMagic currently rates Cupid Limited (CUPID) a Hold, based on a blended score of 45/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.
What is Cupid Limited's fair value?
Our blended DCF and relative-valuation model estimates Cupid Limited's fair value at about ₹182.98, versus a current price of ₹365.95 — roughly 50% downside. On that basis the stock looks overvalued by 50%.
Is Cupid Limited financially healthy?
Cupid Limited scores 100/100 on our financial-health model, placing it in the safe band on the Altman Z-score, with a Piotroski F-score of 4/9.
How has Cupid Limited's share price performed?
Cupid Limited is up 29% over three months, and last traded at ₹365.95. Past performance doesn't predict future returns.
More in Consumer Defensive
Our verdict, fair value, financial-health and checklist are TickerMagic's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.